SUDARSCHEM1,268.50

Sudarshan Chemical Industries Ltd.

· Chemicals
₹ CrorePeersSUDEEPPHRMSTYRENIXSHARDACROPREFEXRCFRALLISRAINPRIVISCLMcap ₹9,958 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SUDARSCHEM
FY26
SUDEEPPHRM
FY26
STYRENIX
FY26
SHARDACROP
FY26
Peer
Median
Valuation — at last close
P/E453.04×78.29×20.53×10.34×20.53× +2106%
P/B2.58×15.26×2.75×2.24×2.75× -6%
EV/EBITDA18.34×62.32×11.38×6.00×11.38× +61%
Market Cap₹9,958 Cr₹13,706 Cr₹3,755 Cr₹7,039 Cr₹7,039 Cr +41%
Growth
Revenue CAGR 3Y62.01%13.17%9.20%11.18% +454%
Revenue CAGR 5Y39.33%16.08%17.07%16.57% +137%
Net Income CAGR 3Y-3.05%-0.03%25.81%12.89% -124%
Revenue YoY (latest Q)5.39%7.14%9.03%8.08% -33%
Net Income YoY (latest Q)88.00%166.37%-38.36%64.00% +37%
Profitability
EBITDA Margin6.03%34.55%9.98%20.43%20.43% -70%
Net Income Margin0.42%27.14%5.32%12.93%12.93% -97%
Return on Common Equity0.58%19.25%13.38%21.70%19.25% -97%
Return on Capital Employed3.56%21.29%12.05%22.15%21.29% -83%
Return on Assets0.42%14.83%7.37%11.78%11.78% -96%
Credit & Quality
Total Debt/Equity0.55×0.17×0.23×0.00×0.17× +224%
Interest Coverage1.47×27.23×11.78×427.86×27.23× -95%
Scale — latest FY
Revenue / Total Income₹9,787 Cr₹642 Cr₹3,438 Cr₹5,268 Cr₹3,438 Cr +185%
Net Income₹40.8 Cr₹174 Cr₹183 Cr₹681 Cr₹183 Cr -78%
Total Assets₹9,723 Cr₹1,175 Cr₹2,483 Cr₹5,780 Cr₹2,483 Cr +292%
EPS₹2.8₹15.5₹103.98₹75.47₹75.47 -96%
Book Value per Share₹490.96₹79.51₹776.75₹347.71₹347.71 +41%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.